<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://prforpharma.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.1.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.4" -->
<!-- generated-on="04/27/2011 4:30 pm" -->
<!-- Debug: Total comment count: 1003 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://prforpharma.com/</loc>
		<lastmod>2011-04-27T16:28:52+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
<!-- Debug: Priority report of postID 356: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/27/working-with-your-regulatory-and-compliance-group/</loc>
		<lastmod>2011-04-27T16:28:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 353: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/26/the-yin-and-yang-of-pharmaceutical-social-media/</loc>
		<lastmod>2011-04-26T15:56:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 351: Comments: 10 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/21/establish-your-social-media-risk-quotient/</loc>
		<lastmod>2011-04-21T20:15:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/13/want-pharma-to-engage-ditch-the-cavalier-attitude/</loc>
		<lastmod>2011-04-13T15:56:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 345: Comments: 18 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/12/social-media-listening-as-a-pillar-of-market-research/</loc>
		<lastmod>2011-04-12T19:25:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 343: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/11/adverse-event-reporting-in-pharma-social-media-not-a-red-herring/</loc>
		<lastmod>2011-04-11T18:58:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 341: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/06/preparing-for-when-the-social-media-game-changes/</loc>
		<lastmod>2011-04-06T13:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 339: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/04/01/mapping-the-patient-pathway-to-the-patient-engagement-spectrum/</loc>
		<lastmod>2011-04-01T15:44:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 337: Comments: 15 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/30/no-social-media-fda-guidance-for-pharma-no-problem/</loc>
		<lastmod>2011-03-30T15:23:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 334: Comments: 6 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/29/the-pharmaceutical-social-media-choice-shape-or-react/</loc>
		<lastmod>2011-03-29T13:28:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 331: Comments: 6 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/23/social-media-roi-uncovering-a-combination-of-leading-and-lagging-indicators/</loc>
		<lastmod>2011-03-23T21:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 329: Comments: 17 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/21/mobile-technology-the-untapped-healthcare-social-media-frontier/</loc>
		<lastmod>2011-03-21T16:35:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 324: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/17/avoiding-the-dreaded-follow-and-forget-on-facebook/</loc>
		<lastmod>2011-03-17T15:44:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 321: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/16/how-simplicity-and-uniqueness-lead-to-pharma-social-media-success/</loc>
		<lastmod>2011-03-16T16:38:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 319: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/15/the-mobile-app-conundrum/</loc>
		<lastmod>2011-03-15T13:13:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 316: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/14/don%e2%80%99t-throw-out-those-old-textbooks-why-maslow-and-drucker-still-matter/</loc>
		<lastmod>2011-03-14T16:29:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 313: Comments: 10 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/11/the-value-of-pre-commerce-to-pharma/</loc>
		<lastmod>2011-03-11T21:29:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 309: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/03/09/big-changes/</loc>
		<lastmod>2011-03-09T19:37:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/chris-iafolla/</loc>
		<lastmod>2011-03-01T13:00:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/pharmaceutical-social-media-resources/</loc>
		<lastmod>2011-03-01T12:58:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 303: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/01/12/the-importance-of-microstrategy/</loc>
		<lastmod>2011-01-12T18:19:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 300: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/01/11/putting-an-end-to-outsized-promises-in-social-media/</loc>
		<lastmod>2011-01-11T21:11:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 298: Comments: 2 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/01/05/the-case-for-influencer-relations/</loc>
		<lastmod>2011-01-05T21:15:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 292: Comments: 6 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2011/01/04/2011-not-the-year-of-pharma-social-media/</loc>
		<lastmod>2011-01-04T19:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 289: Comments: 2 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/22/who%e2%80%99s-behind-the-social-media-agency-curtain/</loc>
		<lastmod>2010-12-22T21:12:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 286: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/21/the-social-media-resource-problem/</loc>
		<lastmod>2010-12-21T16:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 284: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/17/will-fda-guidance-open-the-pharma-social-media-flood-gates/</loc>
		<lastmod>2010-12-17T20:28:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 281: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/14/moving-away-from-the-term-social-media/</loc>
		<lastmod>2010-12-14T19:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 279: Comments: 15 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/10/public-distrust-of-pharma-abandon-social-media/</loc>
		<lastmod>2010-12-10T19:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 276: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/12/03/the-value-of-perspective/</loc>
		<lastmod>2010-12-03T19:03:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 273: Comments: 16 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/10/20/pharma-social-media-putting-the-patient-first/</loc>
		<lastmod>2010-10-20T12:15:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 270: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/10/15/what-is-traditional-pr-anyway/</loc>
		<lastmod>2010-10-15T17:56:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/want-to-get-a-hold-of-me/</loc>
		<lastmod>2010-09-23T15:55:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 261: Comments: 59 of 1003 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2010/09/23/download-free-pharmaceutical-social-media-ebook/</loc>
		<lastmod>2010-09-23T12:09:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 258: Comments: 23 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/09/10/patient-advocates-for-pharmaceutical-social-media/</loc>
		<lastmod>2010-09-10T17:14:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 256: Comments: 17 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/09/02/impact-of-pew-report-on-pharmaceutical-social-media/</loc>
		<lastmod>2010-09-02T17:43:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 251: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/31/pharma-social-media-mission-statement/</loc>
		<lastmod>2010-08-31T19:28:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 248: Comments: 14 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/23/the-dirty-little-secret-of-pharma-regulatory-and-legal-concerns/</loc>
		<lastmod>2010-08-23T21:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 243: Comments: 18 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/20/in-pharma-social-media-quest-don%e2%80%99t-forget-the-basics/</loc>
		<lastmod>2010-08-20T20:19:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 241: Comments: 22 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/17/pharma-social-media-and-its-impact-on-patient-loyalty/</loc>
		<lastmod>2010-08-17T19:50:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 238: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/11/can-online-and-offline-relationship-building-influence-the-pharma-acquisition-price/</loc>
		<lastmod>2010-08-11T19:43:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 236: Comments: 16 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/04/the-pharmaceutical-social-media-oath/</loc>
		<lastmod>2010-08-04T16:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 233: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/08/03/taking-on-too-much-too-fast-in-pharmaceutical-social-media/</loc>
		<lastmod>2010-08-03T20:44:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 229: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/07/08/content-creation-where-pharma-social-media-goes-to-die/</loc>
		<lastmod>2010-07-08T18:38:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 227: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/07/07/failing-to-empower-the-empowered-patient/</loc>
		<lastmod>2010-07-07T16:08:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 224: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/07/01/crisis-is-the-mother-of-invention/</loc>
		<lastmod>2010-07-01T20:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 220: Comments: 10 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/06/25/a-culture-of-nitpickers/</loc>
		<lastmod>2010-06-28T14:37:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 216: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/06/23/pharmaceutical-companies-among-the-least-liked-on-facebook/</loc>
		<lastmod>2010-06-23T15:47:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 214: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/06/15/who-owns-pharma-social-media-who-cares/</loc>
		<lastmod>2010-06-15T20:33:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 210: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/06/04/social-media-for-pharma-crisis-communications/</loc>
		<lastmod>2010-06-04T18:00:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 207: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/05/13/why-recent-pharma-social-media-stumbles-are-a-good-thing/</loc>
		<lastmod>2010-05-13T16:45:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 205: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/04/27/pharmaceutical-call-centers-a-path-to-social-media-success/</loc>
		<lastmod>2010-04-27T20:02:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 203: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/04/26/notice-to-pharmaceutical-marketers-facebook-and-twitter-are-not-social-media/</loc>
		<lastmod>2010-04-26T19:18:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 201: Comments: 1 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/04/05/monday-morning-cup-of-pharma-social-media-coffee/</loc>
		<lastmod>2010-04-05T15:50:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 199: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/04/02/should-pharma-energize-social-media-support-groups/</loc>
		<lastmod>2010-04-02T18:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 196: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/31/raising-money-for-cancer-research/</loc>
		<lastmod>2010-03-31T13:50:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 194: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/24/pew-research-studies-online-behavior-of-patients-with-chronic-illness/</loc>
		<lastmod>2010-03-24T17:38:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 192: Comments: 5 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/23/what-to-expect-from-fda-pharma-social-media-guidance/</loc>
		<lastmod>2010-03-23T19:23:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 190: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/22/setting-pharmaceutical-social-media-strategy/</loc>
		<lastmod>2010-03-22T19:40:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 188: Comments: 5 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/</loc>
		<lastmod>2010-03-18T19:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 184: Comments: 19 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/12/course-correcting-the-sanofi-aventis-social-media-firestorm/</loc>
		<lastmod>2010-03-12T19:19:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 179: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/10/what-social-media-tools-are-you-overlooking/</loc>
		<lastmod>2010-03-10T18:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 177: Comments: 5 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/09/phrma-puts-pressure-on-fda-to-issue-social-media-guidance/</loc>
		<lastmod>2010-03-09T20:08:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/05/pharmaceutical-social-media-in-phases-and-on-a-budget/</loc>
		<lastmod>2010-03-05T21:31:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/04/hoarding-knowledge-does-not-equate-to-power/</loc>
		<lastmod>2010-03-04T15:53:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 5 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/25/crafting-the-message-for-internal-pharma-social-media-audiences/</loc>
		<lastmod>2010-02-25T22:09:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 166: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/</loc>
		<lastmod>2010-02-22T21:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 158: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/19/structuring-your-internal-social-media-team/</loc>
		<lastmod>2010-02-19T17:45:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 156: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/18/the-importance-of-seo-and-social-media-working-together/</loc>
		<lastmod>2010-02-18T21:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 154: Comments: 6 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/17/pharma-social-media-needs-to-embrace-middle-ground/</loc>
		<lastmod>2010-02-17T21:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/12/roi-for-pharma-social-media-the-case-for-change/</loc>
		<lastmod>2010-02-12T20:43:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 141: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/11/can-pharma-marketing-hope-to-create-brand-advocates/</loc>
		<lastmod>2010-02-11T19:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 138: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/10/impact-of-google-and-bing-health-on-pharma-social-media/</loc>
		<lastmod>2010-02-10T20:10:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/</loc>
		<lastmod>2010-02-04T21:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 12 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/</loc>
		<lastmod>2010-02-03T13:44:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/01/analyzing-pharma-social-media-working-group%e2%80%99s-response/</loc>
		<lastmod>2010-02-01T19:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 125: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/29/defining-value-in-pharma-social-media/</loc>
		<lastmod>2010-01-31T15:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/25/comparing-social-media-to-pharma-sales-reps/</loc>
		<lastmod>2010-01-25T21:45:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 112: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/14/don%e2%80%99t-write-off-traditional-pr-entirely-for-social-media/</loc>
		<lastmod>2010-01-22T03:08:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 118: Comments: 10 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/21/why-do-pharma-companies-fire-their-social-media-agency/</loc>
		<lastmod>2010-01-22T03:07:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 116: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/20/social-media-pharmas-sandbox/</loc>
		<lastmod>2010-01-20T20:21:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 110: Comments: 9 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/12/pharma-social-media-echo-chamber/</loc>
		<lastmod>2010-01-12T21:24:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/07/pharma-social-media-there-is-no-easy-road/</loc>
		<lastmod>2010-01-07T17:03:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 104: Comments: 14 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/05/does-shouting-amount-to-pharmaceutical-social-media/</loc>
		<lastmod>2010-01-06T15:01:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 102: Comments: 10 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/22/two-sentences-to-define-pharma-social-media/</loc>
		<lastmod>2009-12-22T19:47:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 99: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/21/listen-closely-for-the-voice-of-the-patient/</loc>
		<lastmod>2009-12-21T22:19:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 96: Comments: 21 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/18/pharma-social-media-sea-change-or-fad/</loc>
		<lastmod>2009-12-18T20:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 94: Comments: 18 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/15/the-pharma-social-media-land-grab/</loc>
		<lastmod>2009-12-15T20:55:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 91: Comments: 23 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/10/educating-legal-and-regulatory-departments-inside-pharmaceutical-companies-on-social-media/</loc>
		<lastmod>2009-12-13T13:23:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 88: Comments: 3 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/09/pharma-social-media-brings-discomfort-in-lack-of-knowledge/</loc>
		<lastmod>2009-12-09T21:00:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 81: Comments: 41 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/03/do-patients-want-pharma-in-social-media/</loc>
		<lastmod>2009-12-04T15:52:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 85: Comments: 20 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/</loc>
		<lastmod>2009-12-04T14:55:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 79: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/01/does-pharma-need-social-media-purists-or-realists/</loc>
		<lastmod>2009-12-01T22:11:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 11 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/24/genzyme-vial-contamination-offers-insight-into-pharma-crisis-communications/</loc>
		<lastmod>2009-11-24T19:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 75: Comments: 19 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/20/why-pharma-needs-social-media/</loc>
		<lastmod>2009-11-20T18:06:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 70: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/18/forget-about-stealth-mode-pr-brings-biotechs-higher-valuations/</loc>
		<lastmod>2009-11-18T20:59:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 68: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/</loc>
		<lastmod>2009-11-16T21:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 63: Comments: 17 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/</loc>
		<lastmod>2009-11-13T17:02:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 61: Comments: 7 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/11/fda-public-hearing-on-social-media-what-will-it-bring/</loc>
		<lastmod>2009-11-11T20:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 59: Comments: 2 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/10/the-implications-of-an-fda-approved-symbol-for-branded-social-media/</loc>
		<lastmod>2009-11-10T16:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 57: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/06/going-the-safe-route-in-social-media/</loc>
		<lastmod>2009-11-06T16:30:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 54: Comments: 5 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/03/regulatory-requirements-a-convenient-excuse-for-pharma-to-avoid-social-media/</loc>
		<lastmod>2009-11-03T23:07:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 52: Comments: 8 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/28/will-the-fda-hearing-have-any-impact-on-pharma-social-media/</loc>
		<lastmod>2009-10-28T20:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 50: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/26/change-the-script-for-pharma-social-media/</loc>
		<lastmod>2009-10-26T20:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 47: Comments: 2 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/22/pharma%e2%80%99s-shift-to-corporate-branding/</loc>
		<lastmod>2009-10-22T20:14:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 4 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/20/deflecting-myopia-is-pharma-marketing-stuck-in-neutral/</loc>
		<lastmod>2009-10-20T21:10:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 43: Comments: 1 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/16/should-pharma-companies-institute-a-no-posting-on-google-sidewiki-policy/</loc>
		<lastmod>2009-10-16T17:56:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 37: Comments: 1 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/15/google-sidewiki-forcing-the-social-media-hand-of-pharma/</loc>
		<lastmod>2009-10-16T13:23:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 35: Comments: 1 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/15/welcome-to-prforpharma-com/</loc>
		<lastmod>2009-10-15T16:03:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 31: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/less-trinkets-more-pr-in-pharma/</loc>
		<lastmod>2009-10-13T17:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 29: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/is-a-press-release-job-safety-for-pharma-pr-managers/</loc>
		<lastmod>2009-10-13T16:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 26: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/pr-in-the-pharma-world/</loc>
		<lastmod>2009-10-13T16:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/social-media-lock-down-in-pharma/</loc>
		<lastmod>2009-10-13T15:45:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 0 of 1003 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/%e2%80%9cpay-for-performance%e2%80%9d-in-pharma-cutting-out-the-middle-man/</loc>
		<lastmod>2009-10-13T15:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/about/</loc>
		<lastmod>2009-10-09T22:40:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>
